Triple
T20451187
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Marvell Technology, Inc. |
E501652
|
entity |
| Predicate | acquired |
P2511
|
FINISHED |
| Object | Innovium, Inc. |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Innovium, Inc. | Statement: [Marvell Technology, Inc., acquired, Innovium, Inc.]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Innovium, Inc. Context triple: [Marvell Technology, Inc., acquired, Innovium, Inc.]
-
A.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
B.
Innoventions
Innoventions was an interactive exhibit pavilion at Epcot in Walt Disney World that showcased emerging technologies and hands-on science displays.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
Aurora Innovation
Aurora Innovation is an autonomous vehicle technology company focused on developing self-driving systems for cars, trucks, and other vehicles.
-
E.
Nanosphere, Inc.
Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Innovium, Inc. Target entity description: Innovium, Inc. was a semiconductor company specializing in high-performance Ethernet switch silicon for data centers and cloud infrastructure.
-
A.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
B.
Innoventions
Innoventions was an interactive exhibit pavilion at Epcot in Walt Disney World that showcased emerging technologies and hands-on science displays.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
Aurora Innovation
Aurora Innovation is an autonomous vehicle technology company focused on developing self-driving systems for cars, trucks, and other vehicles.
-
E.
Nanosphere, Inc.
Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4ac0a1c81908845d0f8a56abce8 |
completed | April 16, 2026, 10:06 a.m. |
| NER | Named-entity recognition | batch_69e68d0296ac819081e74c67d3cc6349 |
completed | April 20, 2026, 8:30 p.m. |
Created at: April 16, 2026, 11:32 a.m.